328 related articles for article (PubMed ID: 25113510)
1. Improving atrial fibrillation detection in patients with implantable cardiac devices by means of a remote monitoring and management application.
Zoppo F; Facchin D; Molon G; Zanotto G; Catanzariti D; Rossillo A; Baccillieri MS; Menard C; Comisso J; Gentili A; Grammatico A; Bertaglia E; Proclemer A
Pacing Clin Electrophysiol; 2014 Dec; 37(12):1610-8. PubMed ID: 25113510
[TBL] [Abstract][Full Text] [Related]
2. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
3. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: the multicentre Italian ANGELS of AF Project.
Boriani G; Santini M; Lunati M; Gasparini M; Proclemer A; Landolina M; Padeletti L; Botto GL; Capucci A; Bianchi S; Biffi M; Ricci RP; Vimercati M; Grammatico A; Lip GY;
Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):182-8. PubMed ID: 22373906
[TBL] [Abstract][Full Text] [Related]
4. Disease management: atrial fibrillation and home monitoring.
Ricci RP
Europace; 2013 Jun; 15 Suppl 1():i35-i39. PubMed ID: 23737228
[TBL] [Abstract][Full Text] [Related]
5. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices.
Lorenzoni G; Folino F; Soriani N; Iliceto S; Gregori D
J Eval Clin Pract; 2014 Oct; 20(5):570-7. PubMed ID: 24766368
[TBL] [Abstract][Full Text] [Related]
7. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Di Cori A; Lilli A; Zucchelli G; Zaca V
Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
[TBL] [Abstract][Full Text] [Related]
8. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
[TBL] [Abstract][Full Text] [Related]
9. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
[TBL] [Abstract][Full Text] [Related]
10. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
[TBL] [Abstract][Full Text] [Related]
11. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
[TBL] [Abstract][Full Text] [Related]
12. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
Healey JS; Wong J
Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
[TBL] [Abstract][Full Text] [Related]
13. Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery.
O'Shea CJ; Brooks AG; Middeldorp ME; Harper C; Hendriks JM; Russo AM; Freeman JV; Gopinathannair R; Varma N; Deering TF; Campbell K; Sanders P
J Interv Card Electrophysiol; 2023 Oct; 66(7):1659-1668. PubMed ID: 36735111
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices.
DeCicco AE; Finkel JB; Greenspon AJ; Frisch DR
Heart Rhythm; 2014 Apr; 11(4):719-24. PubMed ID: 24394157
[TBL] [Abstract][Full Text] [Related]
15. Seasonal trends in atrial fibrillation episodes and physical activity collected daily with a remote monitoring system for cardiac implantable electronic devices.
Censi F; Calcagnini G; Mattei E; Calò L; Curnis A; D'Onofrio A; Vaccari D; Zanotto G; Morichelli L; Rovai N; Gargaro A; Ricci RP
Int J Cardiol; 2017 May; 234():48-52. PubMed ID: 28258846
[TBL] [Abstract][Full Text] [Related]
16. Monitoring in the management of atrial fibrillation.
Lewalter T; Morgan J; Halimi F; Lip G; Dagres N; Blomström-Lundqvist C;
Europace; 2012 Apr; 14(4):591-2. PubMed ID: 22454456
[TBL] [Abstract][Full Text] [Related]
17. Effects of remote monitoring of cardiac implantable electronic devices after stroke or transient ischemic attack.
De Simone V; Zanotto G; Guarise P; Venturato A; Cassinadri E; Bassi M; Bozzolin M; Tondelli S; Giacopelli D; Morando G
J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):551-556. PubMed ID: 31157660
[TBL] [Abstract][Full Text] [Related]
18. Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices.
Lillo-Castellano JM; González-Ferrer JJ; Marina-Breysse M; Martínez-Ferrer JB; Pérez-Álvarez L; Alzueta J; Martínez JG; Rodríguez A; Rodríguez-Pérez JC; Anguera I; Viñolas X; García-Alberola A; Quintanilla JG; Alfonso-Almazán JM; García J; Borrego L; Cañadas-Godoy V; Pérez-Castellano N; Pérez-Villacastín J; Jiménez-Díaz J; Jalife J; Filgueiras-Rama D
Europace; 2020 May; 22(5):704-715. PubMed ID: 31840163
[TBL] [Abstract][Full Text] [Related]
19. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators.
Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M;
Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569
[TBL] [Abstract][Full Text] [Related]
20. The role of implantable devices to treat atrial fibrillation.
Santini L; Santini M
Future Cardiol; 2015; 11(6):689-95. PubMed ID: 26609562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
